AU2003200129A1 - Novel Exendin Agonist Compounds - Google Patents

Novel Exendin Agonist Compounds

Info

Publication number
AU2003200129A1
AU2003200129A1 AU2003200129A AU2003200129A AU2003200129A1 AU 2003200129 A1 AU2003200129 A1 AU 2003200129A1 AU 2003200129 A AU2003200129 A AU 2003200129A AU 2003200129 A AU2003200129 A AU 2003200129A AU 2003200129 A1 AU2003200129 A1 AU 2003200129A1
Authority
AU
Australia
Prior art keywords
agonist compounds
exendin agonist
novel exendin
novel
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU2003200129A
Other versions
AU2003200129B2 (en
Inventor
Nigel Robert Arnold Beeley
Kathryn S. Prickett
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Amylin Pharmaceuticals LLC
AstraZeneca Pharmaceuticals LP
Original Assignee
Amylin Pharmaceuticals LLC
AstraZeneca Pharmaceuticals LP
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU14046/99A external-priority patent/AU757748B2/en
Application filed by Amylin Pharmaceuticals LLC, AstraZeneca Pharmaceuticals LP filed Critical Amylin Pharmaceuticals LLC
Priority to AU2003200129A priority Critical patent/AU2003200129B2/en
Priority claimed from AU2003200129A external-priority patent/AU2003200129B2/en
Publication of AU2003200129A1 publication Critical patent/AU2003200129A1/en
Application granted granted Critical
Publication of AU2003200129B2 publication Critical patent/AU2003200129B2/en
Priority to AU2006225304A priority patent/AU2006225304B2/en
Assigned to ASTRA ZENECA PHARMACEUTICALS LP, AMYLIN PHARMACEUTICALS, LLC reassignment ASTRA ZENECA PHARMACEUTICALS LP Request for Assignment Assignors: AMYLIN PHARMACEUTICALS, INC.
Assigned to ASTRA ZENECA PHARMACEUTICALS LP reassignment ASTRA ZENECA PHARMACEUTICALS LP Request for Assignment Assignors: AMYLIN PHARMACEUTICALS, LLC, ASTRA ZENECA PHARMACEUTICALS LP
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

AU2003200129A 1997-11-14 2003-01-16 Novel Exendin Agonist Compounds Ceased AU2003200129B2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
AU2003200129A AU2003200129B2 (en) 1997-11-14 2003-01-16 Novel Exendin Agonist Compounds
AU2006225304A AU2006225304B2 (en) 1997-11-14 2006-10-09 Novel exendin agonist compounds

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US60/065442 1997-11-14
AU14046/99A AU757748B2 (en) 1997-11-14 1998-11-13 Novel exendin agonist compounds
PCT/US1998/024210 WO1999025727A2 (en) 1997-11-14 1998-11-13 Novel exendin agonist compounds
AU2003200129A AU2003200129B2 (en) 1997-11-14 2003-01-16 Novel Exendin Agonist Compounds

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
AU14046/99A Division AU757748B2 (en) 1997-11-14 1998-11-13 Novel exendin agonist compounds

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU2006225304A Division AU2006225304B2 (en) 1997-11-14 2006-10-09 Novel exendin agonist compounds

Publications (2)

Publication Number Publication Date
AU2003200129A1 true AU2003200129A1 (en) 2003-04-17
AU2003200129B2 AU2003200129B2 (en) 2006-06-22

Family

ID=39338608

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003200129A Ceased AU2003200129B2 (en) 1997-11-14 2003-01-16 Novel Exendin Agonist Compounds

Country Status (1)

Country Link
AU (1) AU2003200129B2 (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5424286A (en) * 1993-05-24 1995-06-13 Eng; John Exendin-3 and exendin-4 polypeptides, and pharmaceutical compositions comprising same
CA2262647C (en) * 1996-08-08 2007-12-04 Amylin Pharmaceuticals, Inc. Methods for regulating gastrointestinal motility
ES2247676T3 (en) * 1997-01-07 2006-03-01 Amylin Pharmaceuticals, Inc. USE OF THE EXENDINAS AND THE AGONISTS OF THE SAME FOR THE REDUCTION OF FOOD INGESTION.
BR9811866A (en) * 1997-08-08 2000-08-15 Amylin Pharmaceuticals Inc Exendin agonist compounds

Similar Documents

Publication Publication Date Title
HK1026627A1 (en) Novel exendin agonist compounds
AU1285499A (en) Somatostatin agonists
AU7210598A (en) Novel compounds
AU6804098A (en) Triazinylaminostilbene compounds
AU4260199A (en) Novel compounds
AU7907498A (en) Novel heterocyclic compounds
AU7907298A (en) Novel heterocyclic compounds
AU2014800A (en) Novel compounds
AU5335798A (en) Stomatic composition
AU5980899A (en) Novel compounds
AU8747498A (en) Food-preservative composition
AU7476598A (en) 18-substituted-19-nor-vitamin d compounds
AU1535699A (en) Novel receptors opg-2
AU6291098A (en) Novel heterocyclic compounds
AUPO941497A0 (en) Novel compounds
AU4814699A (en) Novel compounds
AU8121998A (en) Composition
AUPP042397A0 (en) 5-arylpyrazole compounds
AU7124598A (en) Polymer-platinum compounds
AU1098499A (en) Emulsifier-lipid composition
AU8019998A (en) Fluoromethoximino compounds
AU2187799A (en) Novel taxaneterpine compounds
AUPO691897A0 (en) New compound
AUPO527597A0 (en) Novel heterocyclic compounds
AU2003203955A1 (en) Novel exendin agonist compounds